Drugs / 18Fluorocholine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05891769 | Sep 2023 → Jul 2027 expected | parathyroid gland adenoma | Andrei Iagaru | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18Fluorocholine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05891769 ↗ |
| Route | Intravenous | “administered intravenously” NCT05891769 ↗ |